Lazard Asset Management’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-695
Closed -$39K 1118
2016
Q4
$39K Buy
695
+552
+386% +$31.9K ﹤0.01% 878
2016
Q3
$8K Hold
143
﹤0.01% 935
2016
Q2
$9K Hold
143
﹤0.01% 970
2016
Q1
$9K Sell
143
-2,897
-95% -$193K ﹤0.01% 964
2015
Q4
$223K Buy
3,040
+390
+15% +$27.7K ﹤0.01% 804
2015
Q3
$187K Buy
2,650
+1,100
+71% +$89.2K ﹤0.01% 791
2015
Q2
$134K Buy
1,550
+140
+10% +$10.6K ﹤0.01% 891
2015
Q1
$103K Buy
1,410
+1,095
+348% +$77.7K ﹤0.01% 914
2014
Q4
$22K Hold
315
﹤0.01% 1041
2014
Q3
$21K Buy
+315
New +$22.1K ﹤0.01% 949

Other funds holding LPNT

Lazard Asset Management's LPNT Position: Q1 2017 in Review

Lazard Asset Management sold out of LifePoint Health, Inc. (LPNT) in Q1 2017, closing a stake of 695 shares — an estimated $39K sold.

Lazard Asset Management first reported a position in LPNT in Q3 2014 and held it in 10 quarters. The position peaked at $223K in Q4 2015. 223 funds tracked by Wall St. Rank hold LPNT as of Q1 2017.

  • Lazard Asset Management reported no remaining LifePoint Health, Inc. position as of Q1 2017 after selling out during the quarter.
  • Lazard Asset Management sold 695 LifePoint Health, Inc. shares in Q1 2017, an estimated $39K.
  • Lazard Asset Management first reported a position in LifePoint Health, Inc. in Q3 2014 and held it in 10 quarters.
  • Lazard Asset Management's LifePoint Health, Inc. position peaked at $223K in Q4 2015.
  • 223 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q1 2017.

Based on Lazard Asset Management's 13F filing for Q1 2017, filed 12 May 2017.